Fate Therapeutics Inc. (FATE)
NASDAQ · Healthcare
Fate Therapeutics Inc. Operating Income 2011–2025
Fate Therapeutics Inc. annual/quarterly operating income history and growth rate from 2011 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Fate Therapeutics Inc. operating income for the quarter ending March 31, 2026 was -33.0 M, a 20.06% decrease year-over-year.
- Fate Therapeutics Inc. operating income for the twelve months ending March 31, 2026 was -146.0 M, a 26.94% decrease year-over-year.
- Fate Therapeutics Inc. annual operating income for 2025 was -147.7 M, a 29.76% decrease from 2024.
- Fate Therapeutics Inc. annual operating income for 2024 was -210.3 M, a 10.37% increase from 2023.
- Fate Therapeutics Inc. annual operating income for 2023 was -190.5 M, a 38.22% decrease from 2022.
- Fate Therapeutics Inc. annual operating income for 2022 was -308.4 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Fate Therapeutics Inc. Operating Income — FAQ
Fate Therapeutics Inc. (FATE) operating income over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
What is Fate Therapeutics Inc.'s operating income?
Fate Therapeutics Inc. (FATE) reported operating income of -$148M for fiscal 2025.
Where can I see FATE's operating income history?
The chart and table above show Fate Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.